Chimerix reported 18.71M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Ardelyx ARDX:US $ 43.41M 2.74M
Chimerix CMRX:US 18.71M 501K
Curis CRIS:US $ 13.09M 151K
Dynavax Technologies DVAX:US $ 92.2M 43.38M
Emergent Biosolutions EBS:US $ 363.7M 19.3M
Epizyme EPZM:US $ 69.34M 1.9M
Gilead Sciences GILD:US $ 3579M 392M
Glaxosmithkline GSK:US 7.14B 722M
Life Technologies LIFE:US $ 7.73M 2.72M
Merk MRK:US $ 8328M 1460M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Novavax NVAX:US $ 485.99M 157.86M
Xoma XOMA:US $ 4.28M 20K